Predictive Value of Tumor Thickness for Cervical Lymph-Node Involvement in Squamous Cell Carcinoma of the Oral Cavity A Meta-analysis of Reported Studies

Predictive Value of Tumor Thickness for Cervical Lymph-Node Involvement in Squamous Cell Carcinoma of the Oral Cavity A Meta-analysis of Reported Studies
复制标题

DOI:
10.1002/cncr.24161
复制
发表时间:
2009-04-01
期刊:
影响因子:
6.2
通讯作者:
O'Sullivan, Brian
O'Sullivan, Brian
中科院分区:
医学1区
文献类型:
--
作者:
Huang, Shao Hui;Hwang, David;O'Sullivan, Brian

文献摘要

被引文献

相似文献

背景技术背景:肿瘤厚度(TT)似乎是口腔鳞状细胞癌(OSCC)颈部淋巴结受累的一个强有力的预测因子,但尚未建立一个精确的临床最佳TT临界点。为了解决这个问题,作者进行了荟萃分析。方法:从MEDLINE和EMBASE以及相关文章中引用的交叉引用出版物中识别所有相关文章。淋巴结转移被确认并通过即时颈淋巴清扫术的病理阳性或随访≥ 2年后的颈部复发确定为阳性淋巴结申报(PLND)。计算比值比(OR)以量化TT的预测价值。比较阴性预测值(以及错误预测为没有PLND的患者百分比[FN-PLND]),以确定最佳TT截止点。结果:从72项潜在的研究中选择了16项研究,总计1136例患者。检查了以下TT截止点的数据:3 mm(4项研究,387例患者)、4 mm(9项研究,778例患者)、5 mm(6项研究,367例患者)和6 mm(4项研究,488例患者)。总体组的OR(95% CI)为7.3(5.3-10.1)。TT组FN-PLND的比例分别为5.3%(95%CI,2.0-11.2)、4.5%(2.6-7.2)、16.6%(11.5-22.8)和13.0%(9.7-16.9
BACKGROUND: Tumor thickness (TT) appears to be a strong predictor for cervical lymph-node involvement in squamous cell carcinoma of the oral cavity (OSCC), but a precise clinically optimal TT cutoff point has not been established. To address this question, the authors conducted a meta-analysis. METHODS: All relevant articles were identified from MEDLINE and EMBASE as well as from cross-referenced publications cited in relevant articles. Lymph-node involvement was confirmed and identified as positive lymph-node declaration (PLND) by either pathologic positivity on immediate neck dissection or by neck recurrence identified after follow-up >= 2 years, Odds ratios (OR) were calculated to quantify the predictive value of TT. Negative predictive values (and the percentage of patients falsely predicted to not have PLND [FN-PLND]) were compared to determine the optimal TT cutoff point. RESULTS: Sixteen studies were selected from 72 potential studies, yielding a pooled total of 1136 patients. Data were examined for the following TT cutoff points: 3 mm (4 studies, 387 patients), 4 mm (9 studies, 778 patients), 5 mm (6 studies, 367 patients), and 6 mm (4 studies, 488 patients), The OR (95% CI) was 7.3 (5.3-10.1) for the overall group. The proportion of FN-PLND was 5.3% (95% CI, 2.0-11.2), 4.5% (2.6-7.2), 16.6% (11.5-22.8), and 13.0% (9.7-16.9) for TT